Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Micro Cap & Branchenriese: Heute rein? - Partnerschaft entfacht Übernahmefantasien!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CPLX | ISIN: SE0015961222 | Ticker-Symbol: PIU0
Frankfurt
22.01.25
08:02 Uhr
10,060 Euro
0,000
0,00 %
Branche
IT-Dienstleistungen
Aktienmarkt
Sonstige
1-Jahres-Chart
PROACT IT GROUP AB Chart 1 Jahr
5-Tage-Chart
PROACT IT GROUP AB 5-Tage-Chart
RealtimeGeldBriefZeit
10,08010,28020:24
GlobeNewswire (Europe)
174 Leser
Artikel bewerten:
(1)

ProAct IT Group AB: Jonas Hasselberg resigns as President and CEO of Proact IT Group AB

Finanznachrichten News

Jonas Hasselberg has informed the board of his decision to resign from his role as President and CEO of Proact ("Proact"). The board will now begin the process of appointing a new CEO. During the notice period, Jonas Hasselberg will remain in his position to ensure a smooth transition.

After nearly seven years as CEO, Jonas Hasselberg is leaving Proact to take on new challenges outside the company. Under Jonas' leadership, Proact has grown from an annual revenue of approximately 3 billion SEK to nearly 5 billion SEK and now has around 1,200 employees. During the same period, the company's profits have increased by 70 percent, and recurring revenues have grown to nearly 1.8 billion SEK, primarily driven by a near tripling of the company's cloud revenues.

"It is with very mixed feelings that I have informed the board of my decision to step down as CEO of Proact," says Jonas Hasselberg. "Proact is an outstanding company, and I am proud to have had the privilege of leading and developing the company over nearly seven years alongside all the fantastic employees and the board. For me, this is a good time to hand over to a successor next year while I look forward with excitement and curiosity to the next step in my career."

"The board and I fully respect and understand Jonas' decision to leave his position after leading the group through several successful years," says Anna Söderblom, Chair of the Board of Proact. "I want to express my and the board's sincere gratitude to Jonas Hasselberg for his strong leadership, commitment, and focus on results. Under Jonas' management, Proact has developed fantastically in both financial and operational terms, and we have made significant moves toward our long-term financial goals. Hence, we are in a strong position to continue Proact's growth journey."

Jonas Hasselberg will remain as President and CEO of Proact until a successor is appointed or no later than June 16, 2025. A recruitment process to find his replacement will begin immediately.

This disclosure contains information that Proact IT Group AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 16-12-2024 08:31 CET.

For further information, please contact:
Anna Söderblom, Chair of the Board, Proact IT Group AB, +46 70 940 90 01, anna.soderblom@hhs.se
Jonas Hasselberg, CEO, Proact IT Group AB, +46 722 13 55 56, jonas.hasselberg@proact.eu

About Proact
Proact is Europe's leading specialist in data and information management with focus on cloud services and data centre solutions. We help our customers to store, connect, protect, secure and drive value through their data whilst increasing agility, productivity and efficiency. We've completed thousands of successful projects around the world, have more than 4,000 customers and currently manage hundreds of petabytes of information in the cloud. We employ over 1,200 people in 12 countries across Europe and North America. Founded in 1994, our parent company, Proact IT Group AB (publ), was listed on Nasdaq Stockholm in 1999 (under the symbol PACT). For further information about Proact's activities please visit us at www.proact.eu


© 2024 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.